Literature DB >> 28034982

Enhancing Risk Assessment in Patients Receiving Chronic Opioid Analgesic Therapy Using Natural Language Processing.

Irina V Haller1, Colleen M Renier1, Mitch Juusola1, Paul Hitz1, William Steffen2, Michael J Asmus2, Terri Craig2, Jack Mardekian3, Elizabeth T Masters4, Thomas E Elliott1.   

Abstract

OBJECTIVES: Clinical guidelines for the use of opioids in chronic noncancer pain recommend assessing risk for aberrant drug-related behaviors prior to initiating opioid therapy. Despite recent dramatic increases in prescription opioid misuse and abuse, use of screening tools by clinicians continues to be underutilized. This research evaluated natural language processing (NLP) together with other data extraction techniques for risk assessment of patients considered for opioid therapy as a means of predicting opioid abuse.
DESIGN: Using a retrospective cohort of 3,668 chronic noncancer pain patients with at least one opioid agreement between January 1, 2007, and December 31, 2012, we examined the availability of electronic health record structured and unstructured data to populate the Opioid Risk Tool (ORT) and other selected outcomes. Clinician-documented opioid agreement violations in the clinical notes were determined using NLP techniques followed by manual review of the notes.
RESULTS: Confirmed through manual review, the NLP algorithm had 96.1% sensitivity, 92.8% specificity, and 92.6% positive predictive value in identifying opioid agreement violation. At the time of most recent opioid agreement, automated ORT identified 42.8% of patients as at low risk, 28.2% as at moderate risk, and 29.0% as at high risk for opioid abuse. During a year following the agreement, 22.5% of patients had opioid agreement violations. Patients classified as high risk were three times more likely to violate opioid agreements compared with those with low/moderate risk.
CONCLUSION: Our findings suggest that NLP techniques have potential utility to support clinicians in screening chronic noncancer pain patients considered for long-term opioid therapy.
© 2016 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Chronic Pain; Electronic Health Records; Natural Language Processing; Opioid Analgesics; Risk Assessment

Mesh:

Year:  2017        PMID: 28034982     DOI: 10.1093/pm/pnw283

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  7 in total

1.  Detecting Opioid-Related Aberrant Behavior using Natural Language Processing.

Authors:  Jesse M Lingeman; Priscilla Wang; William Becker; Hong Yu
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

2.  Re-assessing the Validity of the Opioid Risk Tool in a Tertiary Academic Pain Management Center Population.

Authors:  Meredith R Clark; Robert W Hurley; Meredith C B Adams
Journal:  Pain Med       Date:  2018-07-01       Impact factor: 3.750

Review 3.  Making Sense of Big Textual Data for Health Care: Findings from the Section on Clinical Natural Language Processing.

Authors:  A Névéol; P Zweigenbaum
Journal:  Yearb Med Inform       Date:  2017-09-11

Review 4.  Novel digital approaches to the assessment of problematic opioid use.

Authors:  Philip J Freda; Henry R Kranzler; Jason H Moore
Journal:  BioData Min       Date:  2022-07-15       Impact factor: 4.079

5.  Classifying Characteristics of Opioid Use Disorder From Hospital Discharge Summaries Using Natural Language Processing.

Authors:  Melissa N Poulsen; Philip J Freda; Vanessa Troiani; Anahita Davoudi; Danielle L Mowery
Journal:  Front Public Health       Date:  2022-05-09

Review 6.  Can antiepileptic efficacy and epilepsy variables be studied from electronic health records? A review of current approaches.

Authors:  Barbara M Decker; Chloé E Hill; Steven N Baldassano; Pouya Khankhanian
Journal:  Seizure       Date:  2021-01-13       Impact factor: 3.184

7.  Using natural language processing of clinical text to enhance identification of opioid-related overdoses in electronic health records data.

Authors:  Brian Hazlehurst; Carla A Green; Nancy A Perrin; John Brandes; David S Carrell; Andrew Baer; Angela DeVeaugh-Geiss; Paul M Coplan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-06-19       Impact factor: 2.890

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.